104 related articles for article (PubMed ID: 21115941)
1. HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer.
Kamei M; Yamashita S; Tokuishi K; Hashioto T; Moroga T; Suehiro S; Ono K; Miyawaki M; Takeno S; Yamamoto S; Kawahara K
Anticancer Res; 2010 Nov; 30(11):4779-83. PubMed ID: 21115941
[TBL] [Abstract][Full Text] [Related]
2. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.
Verbanac KM; Min CJ; Mannie AE; Lu J; O'Brien KF; Rosman M; Tafra L;
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():368-77. PubMed ID: 20853060
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of interleukin-10 in sentinel lymph node with breast cancer.
Woo SU; Bae JW; Yang JH; Kim JH; Nam SJ; Shin YK
Ann Surg Oncol; 2007 Nov; 14(11):3268-73. PubMed ID: 17762971
[TBL] [Abstract][Full Text] [Related]
5. Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.
Li X; Cao X; Li X; Zhang W; Feng Y
Cancer Sci; 2007 Oct; 98(10):1592-6. PubMed ID: 17651454
[TBL] [Abstract][Full Text] [Related]
6. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
[TBL] [Abstract][Full Text] [Related]
8. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
9. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
10. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].
Ronay G; Zimmermann HD; Tulusan AH
Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387
[No Abstract] [Full Text] [Related]
11. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
[TBL] [Abstract][Full Text] [Related]
12. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study of recurrent breast cancer].
Abe H; Sako H; Umeda T; Eguchi Y; Okino K; Terata N; Kodama M
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1049-54. PubMed ID: 8687220
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis.
Yuan Z; Sanders AJ; Ye L; Wang Y; Jiang WG
Anticancer Res; 2011 Jan; 31(1):303-10. PubMed ID: 21273615
[TBL] [Abstract][Full Text] [Related]
15. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.
Dalal BI; Keown PA; Greenberg AH
Am J Pathol; 1993 Aug; 143(2):381-9. PubMed ID: 8393616
[TBL] [Abstract][Full Text] [Related]
17. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
Galea MH; Athanassiou E; Bell J; Dilks B; Robertson JF; Elston CW; Blamey RW; Ellis IO
J Pathol; 1991 Nov; 165(3):221-7. PubMed ID: 1722247
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G;
Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624
[TBL] [Abstract][Full Text] [Related]
19. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
20. Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study.
Wolf I; Ben-Baruch N; Shapira-Frommer R; Rizel S; Goldberg H; Yaal-Hahoshen N; Klein B; Geffen DB; Kaufman B
Cancer; 2008 Feb; 112(4):731-6. PubMed ID: 18076012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]